Table 2 Repetitive measurements of selected laboratory parameters and comparison of comorbidities in two age group
Variables | < 45 (n = 301) | ≥ 45 (n = 254) | p-value |
|---|---|---|---|
Female/male | 165/136 (55/45%) | 152/102 (60%/40%) | 0.453 |
BMI (kg/m2) | 46.25 (42.17–50.31) | 46.69 (42.02–52.08) | 0.410 |
FPG (mg/dl) | 109 (100–132) | 103.5 (94.5–113) | < 0.001 |
Insulin (mIU/l) | 20.6 (13.6–29.3) | 24.3 (16.5–34.5) | 0.003 |
HOMA-IR | 5.41 (3.26–8.78) | 6.8 (4.19–10.29) | < 0.001 |
HbA1c (%) | 5.5 (5.2–5.9) | 5.8 (5.4–6.6) | < 0.001 |
Cholesterol (mg/dl) | 199 (172–228) | 203.5 (181–236) | 0.013 |
LDL (mg/dl) | 133.2 (113–158) | 141.7 (112–174.7) | 0.069 |
HDL (mg/dl) | 45 (38–56) | 47 (39–59.5) | 0.115 |
TG (mg/dl) | 148 (107–191.5) | 159.5 (121–205) | 0.022 |
Hypertension | 83 (27.6%) | 115 (45.2%) | 0.211 |
Type 2 diabetes mellitus | 40 (13.3%) | 53 (20.9%) | 0.115 |
Insulin resistance | 38 (12.6%) | 45 (17.7%) | 0.022 |
Dyslipidemia | 64 (21.3%) | 70 (27.6%) | 0.115 |